BAVARIAN NORDIC'S KVISTGÅRD FACILITY APPROVED BY AUTHORITIES

Bavarian Nordic A/S announced that its production facility in Kvistgård has been granted Manufacturing Authorisation according to the Medicines Act by the Danish Medicines Agency (Laegemiddelstyrelsen). In continuation of previous authorisations, the authorisation enables Bavarian Nordic to manufacture, analyze and release sterile vaccines for use in humans on the Kvistgård production facility in accordance with full EU cGMP requirements. Drug Newswire (http://www.drugnewswire.com/5415/)